The United States-based Church of Jesus Christ of Latter-day Saints has donated oncology drugs worth Rs. 330 million to Sri Lanka, and signed a separate agreement to supply 600 specialised wheelchairs for patients with spinal cord injuries, the Daily Mirror reported at 3.13 p.m. on Thursday.

The handover took place on 14 October at the Ministry of Health and Mass Media. Lui Wing Chung Mickey, Asia Area Director, and Apapohn Pinsakol Saengsin, Asia Area Manager, represented Latter-day Saint Charities (LDSC), the Utah-based arm of the church.

Ministry Secretary Dr. Anil Jasinghe received the donation and presented a certificate of appreciation. Dr. Dedunu Dias, Director of the ministry’s Medical Supplies Division, also attended.

What was actually donated

The consignment covers three named medicines:

These are established, off-patent cancer drugs rather than novel therapies — the backbone of routine oncology treatment, and precisely the category Sri Lanka’s state system has struggled to keep in stock.

The running total is larger than the headline

The Rs. 330 million is in addition to cancer medicines worth US$2 million, or roughly Rs. 660 million, that the organisation has donated over the past two years. Taken together the programme has now supplied close to Rs. 990 million in oncology drugs.

The implied exchange rate in the ministry’s own conversion is about Rs. 330 to the dollar.

Why this lands where it does

A donation of routine chemotherapy agents is not a neutral event in the current Sri Lankan context. This desk reported on 12 October that cancer patients were spending over Rs. 100,000 a month on drugs the state could not supply. Earlier in the year came an Apeksha Hospital shortage of the cancer drug Neupogen, a doctors’ union warning about a black market in cancer drugs, and questions over how 190,000 cancer injections cleared Customs.

Neither the filing nor the ministry says whether this donation is intended to address any specific shortage, which hospitals will receive the drugs, or how they will be distributed. Given that last point has itself been contentious, it is a notable omission.

The wheelchairs are a second phase, with training attached

The 600 specialised wheelchairs are for patients treated at rehabilitation hospitals and centres nationwide, and mark the second phase of the programme. In the first, in 2023, LDSC donated 570 wheelchairs, distributed through rehabilitation centres over the following three years.

The agreement also includes training for healthcare staff on wheelchair prescription, use and maintenance in line with World Health Organization guidelines, covering doctors, physiotherapists, occupational therapists and wheelchair workshop staff.

The training component is the more substantial half. A specialised wheelchair fitted to the wrong patient, or left unmaintained, stops being an assistive device; WHO guidelines exist because prescription is a clinical act. Attaching training to hardware is what distinguishes this from a straight equipment drop.

Not reported

The filing does not say when the wheelchairs will arrive, what they are worth, how recipients will be selected, or which rehabilitation centres are covered. It gives no quantity for any of the three drugs, no expiry dates, and no indication of whether the National Medicines Regulatory Authority has cleared them or whether Customs clearance is arranged. It does not say what became of the 570 wheelchairs from the first phase beyond that they were distributed.

The Daily Mirror describes the wheelchair arrangement as “an agreement”; one aggregator calls it a memorandum of understanding. The filing does not reproduce the document.

At the time of writing no other verified newsroom had reported the handover — NewsFirst, Daily FT, Colombo Gazette, Island, Daily News and news.lk returned nothing, and Ada Derana remained CloudFront-blocked for a 26th day. One aggregator carried the ministry’s account.